
GLAS
Healthcare · Drug Manufacturers - Specialty & Generic · $119.7M market cap
$1.26+0.01 (+1.2%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -205.3% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 12, 2026 | After the close | -0.06 | -0.02 | +64.8% |
| Mar 24, 2026 | After the close | -0.20 | -0.14 | +30.0% |
| Nov 12, 2025 | After the close | -0.16 | -0.11 | +31.3% |
| Aug 13, 2025 | After the close | -0.05 | 0.09 | +280.0% |
| Mar 25, 2025 | After the close | -0.10 | 0.04 | +140.0% |
| Nov 13, 2024 | After the close | 0.02 | -0.09 | -550.0% |
| Aug 13, 2024 | After the close | -0.01 | 0.12 | +1300.0% |
| May 14, 2024 | After the close | -0.13 | -0.11 | +15.4% |
| Nov 13, 2023 | After the close | -0.05 | -0.10 | -100.0% |
| Aug 14, 2023 | After the close | -0.08 | -0.39 | -387.5% |
| May 15, 2023 | After the close | -0.19 | -0.22 | -15.8% |
Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods. The Retail segment owns, and operates retail cannabis stores, and dispensary operation management services. The Wholesale Biomass segment includes propagation, nursery, flowering canopy,…